tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Incyte Corp (INCY)
NASDAQ:INCY
US Market
INCY
Incyte
RESEARCH TOOLSreports

Incyte (INCY) Stock News & Sentiment

Compare
1,883 Followers
Incyte’s Phase 3 Povorcitinib Study in Hidradenitis Suppurativa Reaches Completion, Setting Up Key Catalyst for INCY Investors
Premium
Company Announcements
Incyte’s Phase 3 Povorcitinib Study in Hidradenitis Suppurativa Reaches Completion, Setting Up Key Catalyst for INCY Investors
1d ago
INCY
Incyte’s INCB123667 Clears a Key Early Hurdle With Completed Phase 1 Study
Premium
Company Announcements
Incyte’s INCB123667 Clears a Key Early Hurdle With Completed Phase 1 Study
3d ago
INCY
3 Best ETFs to Invest In, According to AI Analyst, 1/7/2026
Premium
Market News
3 Best ETFs to Invest In, According to AI Analyst, 1/7/2026
3d ago
FBT
AAPL
Balanced Risk-Reward for Incyte as Monjuvi’s Frontline DLBCL Win Offers Modest Upside in a Crowded Market
Premium
Ratings
Balanced Risk-Reward for Incyte as Monjuvi’s Frontline DLBCL Win Offers Modest Upside in a Crowded Market
5d ago
INCY
Incyte Steps Into Late-Stage Colorectal Cancer Race With New Phase 3 Trial of INCA33890
Premium
Company Announcements
Incyte Steps Into Late-Stage Colorectal Cancer Race With New Phase 3 Trial of INCA33890
23d ago
INCY
Incyte’s mCALR Monoclonal Antibody Shows Promise Amid Complex Myelofibrosis and Thrombocythemia Treatment Landscape
Premium
Ratings
Incyte’s mCALR Monoclonal Antibody Shows Promise Amid Complex Myelofibrosis and Thrombocythemia Treatment Landscape
26d ago
INCY
Incyte’s Latest Study Completion: A Step Forward in Drug Interaction Insights
Premium
Company Announcements
Incyte’s Latest Study Completion: A Step Forward in Drug Interaction Insights
27d ago
INCY
More INCY News >

INCY News on the Web

Bull of the Day: Eli Lilly (LLY)
Zacks
Neutral
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Zacks
Neutral
INCY's Phase III Monjuvi Study Meets Key Goals in First-Line Lymphoma
Zacks
Neutral
Incyte’s Tafasitamab Combination Shows Strong Results in First-Line DLBCL Study: Regulatory Filing Planned for 2026
Market Chameleon
Neutral
Incyte (INCY) Soars 5.5%: Is Further Upside Left in the Stock?
Zacks
Neutral
Incyte Steps Into Late-Stage Colorectal Cancer Race With New Phase 3 Trial of INCA33890
TipRanks News
Neutral
EC Approves Label Expansion of INCY's Lymphoma Drug Minjuvi
Zacks
Bullish
Incyte's Minjuvi Gets Second Nod From EC For R/R Follicular Lymphoma
rttnews
Neutral

News Score - Last 7 Days

Neutral
INCY
Sector Average
Media Buzz
This Week6 articles
Weekly Average2.5 articles
News Sentiment
This Week50%
Sector Average58%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is INCY’s Media Buzz Sentiment?
6 articles about INCY were published this week. In an average week, 2.5 articles are published.
    What is INCY’s weekly average amount of articles?
    In an average week, 2.5 articles about INCY are published.
      What is INCY’s News Sentiment?
      50% of articles about INCY were positive this week, compared to its sector average of 58%.
        Healthcare Stocks that are Trending in the News
        RVMDRevolution Medicines
        KRYSKrystal Biotech
        GNPXGenprex
        REGNRegeneron
        ARDXArdelyx
        Showing the stocks with the most bullish news sentiment over the past week